GlassScriptPhysician profile
Michael Isaac Gurin
NPI 1649708157
$23,052.10
in general payments reported to CMS, 2019-2025
9 companies · $1,957 in 2025
The $1,957 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,488 · 2022: $2,374 · 2023: $7,138 · 2024: $8,095 · 2025: $1,957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,472 · Travel and Lodging: $8,330 · Education: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,472.47 |
| Travel and Lodging | $8,329.67 |
| Education | $388.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $8,677.31 | 2021-2024 | Acticor 7 Vr-T Dx, Plexa Promri, Sentus |
| Abbott Laboratories | $6,818.59 | 2023-2025 | Ensite Precision, Ensite, Aveir |
| Boston Scientific Corporation | $4,508.01 | 2023-2025 | Emblem Mri S-Icd, Farapulse, Versacross Access Solution |
| Medtronic, INC. | $1,476.04 | 2023-2025 | Azure Xt Dr Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $736.96 | 2024-2025 | Carto 3, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $604.43 | 2024 | Carto 3 |
| Philips North America LLC | $107.75 | 2024 | (Ck4) Mcot |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Cardiva Medical, INC. | $24.01 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gurin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.